Arog Pharmaceuticals Llc
Specializing in scientifically validated drug development in treatment of cancer with niche indications.
Discovering, developing and commercializing targeted therapies for anti cancer drugs.
Working to transform the way cancer is treated, with the goal of moving cancer therapy research towards a more manageable disease.
Provides vaccine and drug developers with a clinically relevant system for delivering nucleic acids safely and intact to the interior of the target cell.
Inovio Pharmaceuticals, Inc.
Developing DNA vaccine technology focused on extending the benefits of vaccines by preventing and treating cancers and infectious diseases.
Developing medicines to fight cancer with signal transduction inhibition, cytotoxic agents, antiangiogenesis, cell cyle/apoptosis, iron chelation, metastases and hormone therapy.
OncoMed Pharmaceuticals, Inc.
Developing monoclonal antibodies and other agents that target the biologic pathways critical to tumor initiating cells.
Oncotide Pharmaceuticals Inc.
Develops compounds for oncology that act by restoration of the activity of the protein phosphatase 2A (PP2A) tumor suppressor.
PNP Therapeutics, Inc.
Engaged in the development of a platform technology and proprietary products for the treatment of cancer.
Poniard Pharmaceuticals, Inc.
Focused on the development and commercialization of platinum based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration.
Progenics Pharmaceuticals, Inc.
Develops and commercializes products for the treatment of opioid induced constipation, prostate cancer, human immunodeficiency virus and Hepatitis C virus.
Provectus Pharmaceuticals, Inc.
Developing advanced therapies designed to target and destroy the deadliest cancers, melanoma, liver and breast, while eliminating side effects.
Specializes in the development, manufacturing and delivery of products focused in in vitro diagnostic tests for the screening, monitoring and detection of more than 15 different types of cancer.
Works to bridge the gap between the molecular mechanisms of cancer and clinical practice.
Ziopharm Oncology, Inc.
Specializing in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies.